RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Applied DNA Sciences Stock

Applied DNA Sciences Stocks 2024

Applied DNA Sciences Stocks

654,000

Ticker

APDN

ISIN

US03815U3005

WKN

A2PUTA

In 2024, Applied DNA Sciences had 654,000 outstanding stocks, a 0% change from the 654,000 stocks in the previous year.

The Applied DNA Sciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2025e654
2024e654
2023654
2022448
2021346
2020196
201946
201837
201733
201630
201524
201417
201315
201212
20118
20106
20096
20084
20073
20062
20051
2004-

Applied DNA Sciences shares outstanding

The number of shares was Applied DNA Sciences in 2023 — This indicates how many shares 654,000 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Applied DNA Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Applied DNA Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Applied DNA Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Applied DNA Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Applied DNA Sciences Aktienanalyse

What does Applied DNA Sciences do?

Applied DNA Sciences Inc (APDN) is a US-based company specializing in the development and application of DNA-based technologies. It was founded in 1983 as Identafix Inc., a biometric identification company. In 2002, the focus shifted to DNA technology and the name was changed to Applied DNA Sciences Inc. APDN's business model includes the development, manufacturing, and marketing of DNA technologies for various applications. The company's main segments are security, textiles, and agriculture. In all areas, APDN utilizes its proprietary DNA technology for authentication, testing, monitoring, and traceability. In the security industry, APDN offers a wide range of anti-counterfeiting and authentication solutions. For example, DNA technology can be used to secure identity documents such as passports and driver's licenses. The company has also partnered with the National Football League (NFL) to combat counterfeit merchandise by tagging all items with DNA tags that can be authenticated. In the textiles sector, APDN uses its DNA technology to ensure traceability of cotton and other materials. The company has partnered with various stakeholders in the fashion and retail industry. APDN has developed a comprehensive cotton traceability system that allows customers to trace the entire supply chain of their products. This helps ensure that customers receive products from sustainable production. Agriculture is another important area for APDN. The company utilizes its DNA technology for food traceability. APDN has partnered with a leading food packaging manufacturer to integrate the APDN food traceability system into the packaging. This allows customers to determine the exact origin of their food and ensure that the products come from a safe, trusted source. One of APDN's most well-known applications of DNA technology is the SigNature DNA system. This system uses DNA markers to tag and authenticate products. The SigNature DNA system can be used in a variety of industries, including textiles, agriculture, security, art, and luxury goods. But DNA technology by APDN is also significant in other areas. For example, it can be used in forensics to verify the authenticity of evidence. In medicine, DNA technology can be used to analyze patient DNA sequences and develop personalized medicines. Overall, Applied DNA Sciences Inc has become a significant provider of DNA technologies. The company is active in various industries and offers a wide range of solutions. APDN's DNA technology has the potential to change the way we mark and identify products. Applied DNA Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Applied DNA Sciences's Shares Outstanding

Applied DNA Sciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Applied DNA Sciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Applied DNA Sciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Applied DNA Sciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Applied DNA Sciences stock

How many stocks are there of Applied DNA Sciences?

The current number of stocks of Applied DNA Sciences is 654,000 undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Applied DNA Sciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Applied DNA Sciences evolved in recent years?

The number of shares of Applied DNA Sciences has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Applied DNA Sciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Applied DNA Sciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Applied DNA Sciences pay?

Over the past 12 months, Applied DNA Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Applied DNA Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Applied DNA Sciences?

The current dividend yield of Applied DNA Sciences is .

When does Applied DNA Sciences pay dividends?

Applied DNA Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Applied DNA Sciences?

Applied DNA Sciences paid dividends every year for the past 0 years.

What is the dividend of Applied DNA Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Applied DNA Sciences located?

Applied DNA Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Applied DNA Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Applied DNA Sciences from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Applied DNA Sciences pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Applied DNA Sciences in the year 2023?

In the year 2023, Applied DNA Sciences distributed 0 USD as dividends.

In which currency does Applied DNA Sciences pay out the dividend?

The dividends of Applied DNA Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Applied DNA Sciences

Our stock analysis for Applied DNA Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Applied DNA Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.